We are live on ! Find out more
EAM

EULAV Asset Management Portfolio holdings

AUM $3.13B
1-Year Est. Return 23.04%
This Fund
S&P 500
This Quarter Est. Return
+8.65%
1 Year Est. Return
+23.04%
3 Year Est. Return
+90.7%
5 Year Est. Return
+115.08%
10 Year Est. Return
+583.23%
AUM
$2.68B
AUM Growth
+$147M
Cap. Flow
-$35.9M
Cap. Flow %
-1.34%
Top 10 Hldgs %
23.74%
Holding
195
New
2
Increased
35
Reduced
62
Closed
9

Top Buys

Rank Stock Value
1
WST icon
West Pharmaceutical
WST
+$20.5M
2
HEI icon
HEICO Corp
HEI
+$15.4M
3
WRB icon
W.R. Berkley
WRB
+$12M
4
WCN
Waste Connections
WCN
+$10.3M
5
IT icon
Gartner
IT
+$7.22M

Top Sells

Rank Stock Value
1
SPGI icon
S&P Global
SPGI
+$23.3M
2
INTU icon
Intuit
INTU
+$20.6M
3
ACN icon
Accenture
ACN
+$13.9M
4
NOW icon
ServiceNow
NOW
+$12M
5
CDNS icon
Cadence Design Systems
CDNS
+$9.14M

Sector Composition

Rank Sector Weight
1 Technology 34.59%
2 Industrials 21.71%
3 Healthcare 15.27%
4 Financials 13.4%
5 Consumer Discretionary 6.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WING icon
126
Wingstop
WING
$3.66B
$4.36M 0.16%
21,800
– –
TREX icon
127
Trex
TREX
$4.56B
$4.2M 0.16%
64,000
– –
SITE icon
128
SiteOne Landscape Supply
SITE
$4.15B
$4.18M 0.16%
25,000
+2,500
+11% +$369K
OMCL icon
129
Omnicell
OMCL
$1.69B
$4.14M 0.15%
56,200
– –
FISV
130
Fiserv Inc
FISV
$28.8B
$4.14M 0.15%
32,800
– –
BCPC
131
Balchem Corp
BCPC
$5.23B
$4.08M 0.15%
30,300
– –
RVNC
132
DELISTED
Revance Therapeutics, Inc.
RVNC
$4.05M 0.15%
160,000
+55,000
+52% +$1.71M
NSP icon
133
Insperity
NSP
$2.06B
$3.95M 0.15%
33,200
+3,000
+10% +$356K
TTC icon
134
Toro Company
TTC
$8.72B
$3.82M 0.14%
37,600
– –
MEDP icon
135
Medpace
MEDP
$16.1B
$3.82M 0.14%
15,900
– –
AVGO icon
136
Broadcom
AVGO
$1.85T
$3.74M 0.14%
43,140
-4,940
-10% -$352K
DAL icon
137
Delta Air Lines
DAL
$58.3B
$3.61M 0.13%
76,000
-14,000
-16% -$516K
NPO icon
138
Enpro
NPO
$6.61B
$3.38M 0.13%
25,300
– –
AIT icon
139
Applied Industrial Technologies
AIT
$12.6B
$3.37M 0.13%
23,300
– –
SBUX icon
140
Starbucks
SBUX
$121B
$3.27M 0.12%
33,000
-2,000
-6% -$208K
ECL icon
141
Ecolab
ECL
$78.6B
$3.19M 0.12%
17,100
– –
CNMD icon
142
CONMED
CNMD
$1.41B
$3.08M 0.12%
22,700
– –
WD icon
143
Walker & Dunlop
WD
$1.68B
$3.08M 0.11%
38,900
– –
MMS icon
144
Maximus
MMS
$3.19B
$3.03M 0.11%
35,900
– –
LCII icon
145
LCI Industries
LCII
$2.5B
$3.03M 0.11%
24,000
– –
FSS icon
146
Federal Signal
FSS
$7.6B
$3.02M 0.11%
47,200
+8,100
+21% +$448K
KAI icon
147
Kadant
KAI
$3.63B
$3M 0.11%
13,500
– –
HCSG icon
148
Healthcare Services Group
HCSG
$1.58B
$2.97M 0.11%
198,800
– –
HLT icon
149
Hilton Worldwide
HLT
$72.5B
$2.91M 0.11%
20,000
-1,014
-5% -$144K
PLNT icon
150
Planet Fitness
PLNT
$4.43B
$2.88M 0.11%
42,700
– –
4 5
6
7 8

Similar funds

LFG
Larson Financial Group St Louis, Missouri $3.13B AUM 22.88% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
GKWIM
Gerber Kawasaki Wealth & Investment Management Santa Monica, California $3.14B AUM 22.62% 1-Year Est. Return
DIG
DeepCurrents Investment Group New York $3.12B AUM 12.93% 1-Year Est. Return
BP
BNP Paribas Paris, France $3.15B AUM 22.54% 1-Year Est. Return
CCI
Cevian Capital II St. Helier, Jersey $3.12B AUM 25.62% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
TCG
Tremblant Capital Group West Palm Beach, Florida $3.11B AUM 18.12% 1-Year Est. Return

EULAV Asset Management's Q2 2023 Portfolio in Review

As of Q2 2023, EULAV Asset Management held 195 positions worth $2.68B, up 5.8% from $2.54B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

EULAV Asset Management's Q2 2023 filing shows 2 new, 35 increased, 62 reduced and 9 closed positions. Its largest new stake was Getty Images: 400,000 shares worth $1.95M. The largest sale was S&P Global, an estimated $23.3M.

By sector, the portfolio is most concentrated in Technology at 35% of assets, down from 36% a quarter earlier, followed by Industrials and Healthcare.

  • EULAV Asset Management's largest Q2 2023 buy was Getty Images: 400,000 shares worth $1.95M.
  • EULAV Asset Management added most to West Pharmaceutical in Q2 2023, an estimated $20.5M increase.
  • EULAV Asset Management's biggest Q2 2023 reduction was S&P Global, cutting an estimated $23.3M.
  • EULAV Asset Management fully exited Bio-Rad Laboratories Class A in Q2 2023, selling an estimated $6.51M.
  • EULAV Asset Management's ten largest holdings make up 24% of its $2.68B portfolio in Q2 2023.
  • EULAV Asset Management opened 2 new positions and closed 9 in Q2 2023.
  • EULAV Asset Management's portfolio value rose 5.8% quarter-over-quarter to $2.68B.

Based on EULAV Asset Management's 13F filing for Q2 2023, filed 10 Aug 2023.